Huakang Biomedical Holdings Company Limited(HK:8622)
HK$0.29+0.02 (+7.55%)
HK:8622
Huakang Biomedical Holdings Company Limited financials statements
HK$0.29
At close:+0.02 (+7.55%)
Want to see HK:8622 full AI Analyst Report?
Huakang Biomedical Holdings Company Limited (8622) Financial Statements
0 Followers
Huakang Biomedical Holdings Company Limited Financial Overview
Huakang Biomedical Holdings Company Limited's market cap is currently ¥136.60M. The company's EPS TTM is ¥-0.01; its P/E ratio is -20.12; Huakang Biomedical Holdings Company Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 28.28M | ¥ 25.36M | ¥ 24.63M | ¥ 25.33M | ¥ 26.13M |
| Gross Profit | ¥ 17.77M | ¥ 17.07M | ¥ 16.09M | ¥ 16.91M | ¥ 16.46M |
| Operating Income | ¥ -7.81M | ¥ -5.69M | ¥ -7.39M | ¥ -5.09M | ¥ -4.33M |
| EBITDA | ¥ -4.17M | ¥ -1.68M | ¥ -2.55M | ¥ 188.00K | ¥ -852.00K |
| Net Income | ¥ -5.01M | ¥ -4.16M | ¥ -5.78M | ¥ -3.08M | ¥ -4.22M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 41.96M | ¥ 36.49M | ¥ 32.94M | ¥ 33.30M | ¥ 36.21M |
| Total Assets | ¥ 66.64M | ¥ 65.22M | ¥ 65.31M | ¥ 66.40M | ¥ 67.06M |
| Total Debt | ¥ 4.96M | ¥ 4.08M | ¥ 5.14M | ¥ 1.88M | ¥ 1.78M |
| Net Debt | ¥ -32.00M | ¥ -27.41M | ¥ -27.80M | ¥ -31.43M | ¥ -34.42M |
| Total Liabilities | ¥ 15.46M | ¥ 11.17M | ¥ 14.30M | ¥ 9.88M | ¥ 9.36M |
| Stockholders' Equity | ¥ 51.15M | ¥ 54.05M | ¥ 51.02M | ¥ 56.52M | ¥ 57.70M |
| Cash Flow | |||||
| Free Cash Flow | ¥ -3.29M | ¥ -5.05M | ¥ -1.55M | ¥ 475.00K | ¥ -4.71M |
| Operating Cash Flow | ¥ -2.21M | ¥ -3.06M | ¥ -48.00K | ¥ 1.29M | ¥ -2.38M |
| Investing Cash Flow | ¥ 2.32M | ¥ -4.42M | ¥ -1.15M | ¥ -6.11M | ¥ -2.06M |
| Financing Cash Flow | ¥ 4.78M | ¥ 6.30M | ¥ 1.02M | ¥ 2.32M | ¥ -1.37M |
Currency in CNY
